
Regenova Pharma applies deep learning to identify therapeutic antibodies for targeted therapies. The company uses advanced AI models to analyze antibody sequences, structures, and activity to accelerate discovery and optimization. It operates as a B2B biotech platform serving pharmaceutical and biotech developers, integrating core AI and machine learning methods into the discovery workflow. Regenova targets the broader biopharma market to scale antibody development and shorten development timelines.

Regenova Pharma applies deep learning to identify therapeutic antibodies for targeted therapies. The company uses advanced AI models to analyze antibody sequences, structures, and activity to accelerate discovery and optimization. It operates as a B2B biotech platform serving pharmaceutical and biotech developers, integrating core AI and machine learning methods into the discovery workflow. Regenova targets the broader biopharma market to scale antibody development and shorten development timelines.